Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00607230 |
|
Recruitment Status :
Completed
First Posted : February 5, 2008
Last Update Posted : November 5, 2013
|
Sponsor:
Massachusetts General Hospital
Information provided by (Responsible Party):
David M. Nathan, MD, Massachusetts General Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2010 |
| Actual Study Completion Date : | February 2011 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):